Press "Enter" to skip to content

Genetic Variant May Make Ozempic and Similar Weight-Loss Drugs More Effective

NEW RESEARCHGLP-1

A new study published in Nature found that people with a specific genetic variant may see better results from GLP-1 weight-loss drugs like Ozempic and Mounjaro. This research could help doctors predict which patients are most likely to benefit from these medications.

Source: Foxnews

Sign up to receive our newsletter and keep up with latest content!

Mission News Theme by Compete Themes.